Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 1

Results: 44

Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply.

Published in:

2025

By:

Zhao, Jianhui;
Xue, Erxu;
Liu, Zhanju;
Li, Xue

Publication type:

Editorial

A Message From the Editors.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 4, doi. 10.1111/apt.18404

By:

Howden, Colin W.;
Loomba, Rohit

Publication type:

Article

Review Article: Green Management of IBD—New Paradigms for an Eco‐Friendly Approach.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 65, doi. 10.1111/apt.18399

By:

Cammarota, Giovanni;
Laterza, Lucrezia;
Bibbò, Stefano;
Fusco, William;
Rozera, Tommaso;
Di Brino, Eugenio;
Porcari, Serena;
Scaldaferri, Franco;
Ianiro, Gianluca;
Gasbarrini, Antonio;
Armuzzi, Alessandro

Publication type:

Article

Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials.

Published in:

2025

By:

Roberts, Andrew T.;
Makar, Joseph;
Abdelmalak, Jonathan;
Sinclair, Marie;
Testro, Adam;
Majumdar, Avik

Publication type:

Literature Review

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply.

Published in:

2025

By:

Solitano, Virginia;
Zou, Guangyong;
Jairath, Vipul

Publication type:

Letter to the Editor

Letter: Combination Therapies With Vitamin E for Metabolic Dysfunction‐Associated Steatotic Liver Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 238, doi. 10.1111/apt.18393

By:

Polyzos, Stergios A.;
Kountouras, Jannis

Publication type:

Article

AP&T: Editors' Declarations of Interest.

Published in:: Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 6, doi. 10.1111/apt.18389
Publication type:: Article

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 75, doi. 10.1111/apt.18386

By:

Shiffman, Mitchell;
Reddy, K. Rajender;
Leise, Michael D.;
Qureshi, Kamran;
Smith, Alastair D.;
Helmke, Steve;
Kittelson, John;
McRae, Michael P.;
Imperial, Joanne C.;
Everson, Gregory T.

Publication type:

Article

Meta‐Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials.

Published in:

2025

By:

Rivas, Angelica;
Ahmed, Newaz Shubidito;
Yuan, Yuhong;
Qasim, Anila;
O'Gorman, David B.;
Feagan, Brian G.;
Jairath, Vipul;
Bredenoord, Albert J.;
Dellon, Evan S.;
Ma, Christopher

Publication type:

Literature Review

Letter: Analysis of "Faecal Biomarkers for Diagnosis and Prediction of Disease Course in Treatment‐Naïve Patients With IBD"—Authors' Reply.

Published in:

2025

By:

Ling Lundström, Maria;
Lampinen, Maria;
Carlson, Marie;
Halfvarson, Jonas

Publication type:

Letter to the Editor

Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease—Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 228, doi. 10.1111/apt.18368

By:

Hartl, Lukas;
Schwarz, Michael;
Simbrunner, Benedikt;
Jachs, Mathias;
Wolf, Peter;
Bauer, David Josef Maria;
Scheiner, Bernhard;
Balcar, Lorenz;
Semmler, Georg;
Hofer, Benedikt Silvester;
Dominik, Nina;
Marculescu, Rodrig;
Trauner, Michael;
Mandorfer, Mattias;
Reiberger, Thomas

Publication type:

Article

Editorial: Timely Follow‐Up in Cirrhosis: How Does It Work?

Published in:

2025

By:

Kimer, Nina;
Gluud, Lise Lotte

Publication type:

Editorial

Letter: Timely Follow‐Up in Cirrhosis—A Key Public Health Intervention.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 210, doi. 10.1111/apt.18365

By:

Tan, Mo‐Yao;
Zhang, Ping;
Gao, Ming

Publication type:

Article

Letter: Why Assessment of ChILI Severity Accurately Matters?

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 240, doi. 10.1111/apt.18385

By:

Riveiro‐Barciela, Mar;
Aithal, Guruprasad P.

Publication type:

Article

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS. Authors' Reply.

Published in:

2025

By:

O'Connor, Anthony;
Gill, Sarah;
Neary, Elaine;
White, Sarah;
Ford, Alexander C.

Publication type:

Editorial

Letter: Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 232, doi. 10.1111/apt.18381

By:

Wu, Kuo‐Cheng;
Lee, I‐Cheng

Publication type:

Article

Meta‐Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes.

Published in:

2025

By:

Karimzadhagh, Sahand;
Abbaspour, Elahe;
Shahriarinamin, Maryam;
Shamsi, Pourya;
Poursadrolah, Selvana;
Khorasani, Mehrdad;
Daghighi, Mahzad;
Malek, Arash;
Talesh, Jouan Taheri;
Makharia, Govind K.;
Rostami‐Nejad, Mohammad

Publication type:

Literature Review

Editorial: Timely Follow‐Up in Cirrhosis—How Does It Work? Authors' Reply.

Published in:

2025

By:

Schechter, Max S.;
Hagström, Hannes

Publication type:

Editorial

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS.

Published in:

2025

By:

Katzenstein, Cecilia;
Keefer, Laurie

Publication type:

Editorial

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue? Authors' Reply.

Published in:

2025

By:

Wang, Ting;
Zou, Deli;
Qi, Xingshun

Publication type:

Editorial

Editorial: Stopping NUCs—When to Restart NUCs for the Best Outcome?

Published in:

2025

By:

Urbanek‐Quaing, Melanie;
Cornberg, Markus

Publication type:

Case Study

Editorial: Understanding the Trade‐Offs When Considering Positivity Threshold of Faecal Immunochemical Tests.

Published in:

2025

By:

Imperiale, Thomas F.

Publication type:

Editorial

Letter: Bowel Preparation Quality in Patients With Crohn's Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 234, doi. 10.1111/apt.18350

By:

Schildkraut, Tamar;
Ding, Nik S.;
Chetwood, John David

Publication type:

Article

Letter: 'Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation'.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 230, doi. 10.1111/apt.18345

By:

Xu, You‐Jian;
Pang, Hui‐Ming

Publication type:

Article

Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 226, doi. 10.1111/apt.18339

By:

Osama, Muhammad;
Ubaid, Safiyyah;
Ubaid, Maryam

Publication type:

Article

Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 177, doi. 10.1111/apt.18337

By:

O'Connor, Anthony;
Gill, Sarah;
Neary, Elaine;
White, Sarah;
Ford, Alexander C.

Publication type:

Article

Letter: Critical Insights on a Nationwide Cohort Study of Inflammatory Bowel Disease, Histological Activity and Fracture Risk.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 216, doi. 10.1111/apt.18336

By:

Khan, Saad;
Munir, Aqsa;
Henna, Fathimathul;
Fatima, Syeda Mashal;
Ahmad, Zulfiqar

Publication type:

Article

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?

Published in:

2025

By:

Alferink, Louise J. M.;
de Knegt, Robert J.

Publication type:

Editorial

Letter: Assessing the Durability of Treatment Effects: Long‐Term Outcomes of ESWL and ERCP for Pancreatic Duct Stones in Chronic Pancreatitis—Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 224, doi. 10.1111/apt.18333

By:

Liu, Yu;
Hu, Liang‐Hao

Publication type:

Article

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 132, doi. 10.1111/apt.18318

By:

Leong, Rupert W.;
Sakiris, Anthony;
Arzivian, Arteen;
Chetwood, John David;
Chaemsupaphan, Thanaboon;
Sparrow, Miles P.;
Kamm, Michael A.;
Kariayawasam, Viraj

Publication type:

Article

Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 168, doi. 10.1111/apt.18335

By:

Kim, Kunhee;
Yim, Seung Hyuk;
Lee, Jae Geun;
Joo, Dong Jin;
Kim, Myoung Soo;
Park, Jun Yong;
Ahn, Sang Hoon;
Kim, Deok‐Gie;
Lee, Hye Won

Publication type:

Article

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 159, doi. 10.1111/apt.18330

By:

Benech, Nicolas;
Cassir, Nadim;
Alric, Laurent;
Barbut, Frédéric;
Batista, Rui;
Bleibtreu, Alexandre;
Briot, Thomas;
Davido, Benjamin;
Galperine, Tatiana;
Joly, Anne‐Christine;
Kapel, Nathalie;
Melchior, Chloé;
Mosca, Alexis;
Nebbad, Biba;
Pigneur, Bénédicte;
Schneider, Stéphane M.;
Wasiak, Mathieu;
Scanzi, Julien;
Sokol, Harry;
Schneider, Stéphane

Publication type:

Article

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 145, doi. 10.1111/apt.18328

By:

van Liere, Elsa L. S. A.;
Ramsoekh, Dewkoemar;
Daulton, Emma;
Dakkak, Maya;
van Lingen, Joris M.;
Stewart, Trenton K.;
Bosch, Sofie;
Carvalho, Beatriz;
Dekker, Evelien;
Jacobs, Maarten A. J. M.;
Koornstra, Jan Jacob;
Kuijvenhoven, Johan P.;
van Leerdam, Monique E.;
de Meij, Tim G. J.;
Meijer, Gerrit A.;
Spaander, Manon C. W.;
Covington, James A.;
de Boer, Nanne K. H.

Publication type:

Article

Editorial: Allostatic Load and Inflammatory Bowel Disease.

Published in:

2025

By:

Mendoza, Jeli;
Irwin, James

Publication type:

Editorial

Editorial: Metabolic Dysfunction and Alcohol—Two Sides of the Same Coin.

Published in:

2025

By:

Ayares, Gustavo;
Díaz, Luis Antonio

Publication type:

Editorial

Performance of Faecal Immunochemical Testing for Colorectal Cancer Screening at Varying Positivity Thresholds.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 122, doi. 10.1111/apt.18314

By:

Randel, Kristin Ranheim;
Botteri, Edoardo;
de Lange, Thomas;
Schult, Anna Lisa;
Eskeland, Sigrun Losada;
El‐Safadi, Badboni;
Norvard, Espen R.;
Bolstad, Nils;
Bretthauer, Michael;
Hoff, Geir;
Holme, Øyvind

Publication type:

Article

Letter: Assessing the Durability of Treatment Effects: Long‐Term Outcomes of ESWL and ERCP for Pancreatic Duct Stones in Chronic Pancreatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 222, doi. 10.1111/apt.18321

By:

Tang, Wei‐Zhen;
Deng, Bo‐Yuan;
Liu, Tai‐Hang

Publication type:

Article

Letter: Differences in Disease Characteristics and Treatment Exposures Between Paediatric and Adult‐Onset IBD.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 214, doi. 10.1111/apt.18313

By:

Chen, Xinli;
Wang, Wenjun;
Lv, Jianyu

Publication type:

Article

Letter: Using non‐invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients.

Published in:

2025

By:

Meng, Wenjun;
Yao, Ping;
Dan, Yuan

Publication type:

Letter to the Editor

Issue Information.

Published in:: Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 1, doi. 10.1111/apt.18069
Publication type:: Article

Letter: Analysis of 'Faecal Biomarkers for Diagnosis and Prediction of Disease Course in Treatment‐Naive Patients With IBD'.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 218, doi. 10.1111/apt.18312

By:

Chen, Yuxiang;
Hu, Wenjian;
Qin, Fengfeng

Publication type:

Article

Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 109, doi. 10.1111/apt.18309

By:

Schechter, Max S.;
Widman, Linnea;
Wester, Axel;
Shang, Ying;
Stål, Per;
Fortune, Brett;
Hagström, Hannes

Publication type:

Article

Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 99, doi. 10.1111/apt.18291

By:

Shiha, Gamal;
Hassan, Ayman;
Mousa, Nasser;
El‐domiaty, Nada;
Mikhail, Nabiel;
Gameaa, Reham;
Kobtan, Abdelrahman;
El Bassat, Hanan;
Sharaf‐Eldin, Mohamed;
Waked, Imam;
Eslam, Mohamed;
Soliman, Riham

Publication type:

Article

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 88, doi. 10.1111/apt.18289

By:

Hartl, Lukas;
Schwarz, Michael;
Simbrunner, Benedikt;
Jachs, Mathias;
Wolf, Peter;
Bauer, David Josef Maria;
Scheiner, Bernhard;
Balcar, Lorenz;
Semmler, Georg;
Hofer, Benedikt Silvester;
Dominik, Nina;
Marculescu, Rodrig;
Trauner, Michael;
Mandorfer, Mattias;
Reiberger, Thomas

Publication type:

Article